vs
Side-by-side financial comparison of CXApp Inc. (CXAI) and PLUS THERAPEUTICS, INC. (PSTV). Click either name above to swap in a different company.
PLUS THERAPEUTICS, INC. is the larger business by last-quarter revenue ($1.4M vs $1.0M, roughly 1.3× CXApp Inc.). PLUS THERAPEUTICS, INC. runs the higher net margin — -417.9% vs -544.1%, a 126.2% gap on every dollar of revenue. On growth, PLUS THERAPEUTICS, INC. posted the faster year-over-year revenue change (-3.2% vs -38.5%). CXApp Inc. produced more free cash flow last quarter ($-3.6M vs $-6.3M). Over the past eight quarters, PLUS THERAPEUTICS, INC.'s revenue compounded faster (-9.7% CAGR vs -25.0%).
CXApp Inc. is a technology firm specializing in digital workplace experience solutions. It offers cloud-based software tools for employee engagement, office space optimization, visitor management, and hybrid work coordination, serving mid-to-large enterprises across North America, APAC and Europe.
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company headquartered in Houston, Texas, that develops targeted radiotherapeutics and diagnostic services for brain and central nervous system (CNS) cancers. The company’s lead therapeutic candidate, marketed as REYOBIQ™, is an investigational liposomal radiopharmaceutical under clinical evaluation for recurrent glioblastoma, leptomeningeal metastases, and certain pediatric brain cancers. Plus Therapeutics also commercialized a molecu...
CXAI vs PSTV — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.0M | $1.4M |
| Net Profit | $-5.6M | $-5.7M |
| Gross Margin | 86.9% | — |
| Operating Margin | -576.9% | -420.0% |
| Net Margin | -544.1% | -417.9% |
| Revenue YoY | -38.5% | -3.2% |
| Net Profit YoY | -56.7% | -46.4% |
| EPS (diluted) | — | $0.95 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.0M | $1.4M | ||
| Q3 25 | $1.1M | $1.4M | ||
| Q2 25 | $1.2M | $1.4M | ||
| Q1 25 | $1.2M | $1.1M | ||
| Q4 24 | $1.7M | $1.4M | ||
| Q3 24 | $1.9M | $1.5M | ||
| Q2 24 | $1.8M | $1.3M | ||
| Q1 24 | $1.8M | $1.7M |
| Q4 25 | $-5.6M | $-5.7M | ||
| Q3 25 | $-3.2M | $-4.4M | ||
| Q2 25 | $-3.1M | $5.2M | ||
| Q1 25 | $-1.6M | $-17.4M | ||
| Q4 24 | $-3.5M | $-3.9M | ||
| Q3 24 | $-5.4M | $-2.9M | ||
| Q2 24 | $-5.3M | $-2.9M | ||
| Q1 24 | $-5.2M | $-3.3M |
| Q4 25 | 86.9% | — | ||
| Q3 25 | 89.0% | — | ||
| Q2 25 | 86.0% | — | ||
| Q1 25 | 87.7% | — | ||
| Q4 24 | 86.0% | — | ||
| Q3 24 | 80.4% | — | ||
| Q2 24 | 80.0% | — | ||
| Q1 24 | 82.0% | — |
| Q4 25 | -576.9% | -420.0% | ||
| Q3 25 | -343.4% | -320.8% | ||
| Q2 25 | -336.1% | -110.6% | ||
| Q1 25 | -306.0% | -333.9% | ||
| Q4 24 | -169.7% | -276.2% | ||
| Q3 24 | -194.3% | -260.9% | ||
| Q2 24 | -206.7% | -289.1% | ||
| Q1 24 | -197.3% | -196.7% |
| Q4 25 | -544.1% | -417.9% | ||
| Q3 25 | -283.4% | -316.6% | ||
| Q2 25 | -256.7% | 370.6% | ||
| Q1 25 | -132.0% | -1643.2% | ||
| Q4 24 | -213.6% | -276.4% | ||
| Q3 24 | -286.5% | -197.4% | ||
| Q2 24 | -297.6% | -229.9% | ||
| Q1 24 | -284.4% | -194.5% |
| Q4 25 | — | $0.95 | ||
| Q3 25 | — | $-0.04 | ||
| Q2 25 | — | $-0.01 | ||
| Q1 25 | — | $-1.19 | ||
| Q4 24 | — | $-0.51 | ||
| Q3 24 | — | $-0.37 | ||
| Q2 24 | — | $-0.71 | ||
| Q1 24 | — | $-0.75 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $11.1M | $8.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $14.0M | $4.0M |
| Total Assets | $32.4M | $16.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $11.1M | $8.6M | ||
| Q3 25 | $5.1M | $16.6M | ||
| Q2 25 | $4.9M | $6.9M | ||
| Q1 25 | $3.9M | $9.9M | ||
| Q4 24 | $4.9M | $3.6M | ||
| Q3 24 | — | $4.8M | ||
| Q2 24 | — | $8.4M | ||
| Q1 24 | — | $3.2M |
| Q4 25 | $14.0M | $4.0M | ||
| Q3 25 | $15.2M | $5.1M | ||
| Q2 25 | $14.3M | $3.0M | ||
| Q1 25 | $15.6M | $-23.6M | ||
| Q4 24 | $15.6M | $-8.9M | ||
| Q3 24 | $13.6M | $-5.2M | ||
| Q2 24 | $16.3M | $-7.6M | ||
| Q1 24 | $20.9M | $-4.8M |
| Q4 25 | $32.4M | $16.3M | ||
| Q3 25 | $28.5M | $18.7M | ||
| Q2 25 | $29.6M | $10.3M | ||
| Q1 25 | $29.3M | $12.1M | ||
| Q4 24 | $31.8M | $6.6M | ||
| Q3 24 | — | $7.0M | ||
| Q2 24 | — | $11.2M | ||
| Q1 24 | — | $5.6M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-3.6M | $-6.3M |
| Free Cash FlowOCF − Capex | $-3.6M | $-6.3M |
| FCF MarginFCF / Revenue | -355.5% | -459.9% |
| Capex IntensityCapex / Revenue | 0.2% | 2.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-10.4M | $-20.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-3.6M | $-6.3M | ||
| Q3 25 | $-2.8M | $-2.5M | ||
| Q2 25 | $-3.0M | $-5.8M | ||
| Q1 25 | $-979.0K | $-6.2M | ||
| Q4 24 | $-2.7M | $-1.2M | ||
| Q3 24 | $-2.1M | $-3.7M | ||
| Q2 24 | $-1.9M | $-1.1M | ||
| Q1 24 | $-650.0K | $-4.5M |
| Q4 25 | $-3.6M | $-6.3M | ||
| Q3 25 | $-2.8M | $-2.6M | ||
| Q2 25 | $-3.0M | $-5.8M | ||
| Q1 25 | $-984.0K | $-6.2M | ||
| Q4 24 | — | $-1.2M | ||
| Q3 24 | $-2.1M | $-3.7M | ||
| Q2 24 | $-1.9M | $-1.2M | ||
| Q1 24 | $-668.0K | $-4.6M |
| Q4 25 | -355.5% | -459.9% | ||
| Q3 25 | -248.1% | -184.3% | ||
| Q2 25 | -247.2% | -417.6% | ||
| Q1 25 | -80.4% | -583.1% | ||
| Q4 24 | — | -86.5% | ||
| Q3 24 | -109.3% | -253.7% | ||
| Q2 24 | -108.6% | -96.2% | ||
| Q1 24 | -36.7% | -271.5% |
| Q4 25 | 0.2% | 2.2% | ||
| Q3 25 | 0.4% | 1.9% | ||
| Q2 25 | 0.9% | 0.5% | ||
| Q1 25 | 0.4% | 0.3% | ||
| Q4 24 | 0.0% | 0.8% | ||
| Q3 24 | 0.2% | 1.0% | ||
| Q2 24 | 0.5% | 6.3% | ||
| Q1 24 | 1.0% | 2.4% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -1.13× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
